Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Talseth-Palmer BA"'
Publikováno v:
Clinical Interventions in Aging, Vol Volume 14, Pp 145-154 (2019)
Bodil Røyset,1 Bente A Talseth-Palmer,2–4 Stian Lydersen,5 Per G Farup6,7 1Department for Medicine and Rehabilitation, Møre og Romsdal Hospital Trust, Ålesund, Norway; 2Department for Research, Innovation, Education and Competence Development, M
Externí odkaz:
https://doaj.org/article/accad4534abb48b4b692b7978ffab4d1
Autor:
Picelli, S, Bermejo, JL, Chang-Claude, J, Hoffmeister, M, Fernandez-Rozadilla, C, Carracedo, A, Castells, A, Castellvi-Bel, S, Naccarati, A, Pardini, B, Vodickova, L, Muller, H, Talseth-Palmer, BA, Stibbard, G, Peterlongo, P, Nici, C, Veneroni, S, Li, L, Casey, G, Tenesa, A, Farrington, SM, Tomlinson, I, Moreno, V, van Wezel, T, Wijnen, J, Dunlop, M, Radice, P, Scott, RJ, Vodicka, P, Ruiz-Ponte, C, Brenner, H, Buch, S, Volzke, H, Hampe, J, Schafmayer, C, Lindblom, A, González Juan D., Roman, E, Ramon, T., Poca, M, Concepcion, Ma M., Martin, M, Pétriz L., EPICOLON Consortium
Publikováno v:
PLoS One
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
In the last four years, Genome-Wide Association Studies (GWAS) have identified sixteen low-penetrance polymorphisms on fourteen different loci associated with colorectal cancer (CRC). Due to the low risks conferred by known common variants, most of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::efc3deff81dd81330531a37dc372b887
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=9677
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=9677
Autor:
Wiik MU; Research Unit, Ålesund Hospital, Møre and Romsdal Hospital Trust, Ålesund, Norway.; Department of Medicine, Ålesund Hospital, Møre and Romsdal Hospital Trust, Ålesund, Norway.; Department of Biological Sciences, Faculty of Natural Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Negline M; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia., Beisvåg V; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491, Trondheim, Norway.; St. Olav's University Hospital, Central Staff, 7006, Trondheim, Norway., Clapham M; School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia., Holliday E; School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia., Dueñas N; Hereditary Cancer Program, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain.; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Brunet J; Hereditary Cancer Program, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain.; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Pineda M; Hereditary Cancer Program, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain.; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Bonifaci N; Hereditary Cancer Program, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain.; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Aretz S; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.; Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany., Klinkhammer H; Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany.; Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Bonn, Germany., Spier I; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany.; Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany., Perne C; Institute of Human Genetics, Medical Faculty, University of Bonn, Bonn, Germany., Mayr A; Institute for Medical Biometry, Informatics and Epidemiology, University Hospital Bonn, Bonn, Germany., Valle L; Hereditary Cancer Program, Catalan Institute of Oncology, Hospitalet de Llobregat, Barcelona, Spain.; Oncobell Program, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Lubinski J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Sjursen W; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491, Trondheim, Norway.; Department of Medical Genetics, St Olavs University Hospital, Trondheim, Norway., Scott RJ; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.; Department of Molecular Genetics, NSW Health Pathology, John Hunter Hospital, Newcastle, NSW, Australia., Talseth-Palmer BA; Research Unit, Ålesund Hospital, Møre and Romsdal Hospital Trust, Ålesund, Norway. bente.talseth-palmer@newcastle.edu.au.; School of Biomedical Science and Pharmacy, College of Health, Medicine and Wellbeing, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia. bente.talseth-palmer@newcastle.edu.au.; NSW Health Pathology, Newcastle, NSW, Australia. bente.talseth-palmer@newcastle.edu.au.
Publikováno v:
Scientific reports [Sci Rep] 2023 Nov 01; Vol. 13 (1), pp. 18783. Date of Electronic Publication: 2023 Nov 01.
Autor:
Wiik MU; Research Unit, Ålesund Hospital, Møre and Romsdal Hospital Trust, Ålesund, Norway., Evans TJ; Hunter Medical Research Institute, New Lambton Heights, Australia., Belhadj S; Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL and CIBERONC, Hospitalet de Llobregat, Barcelona, Spain., Bolton KA; School of Biomedical Science and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia., Dymerska D; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Jagmohan-Changur S; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands., Capellá G; Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL and CIBERONC, Hospitalet de Llobregat, Barcelona, Spain., Kurzawski G; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Wijnen JT; Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands., Valle L; Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL and CIBERONC, Hospitalet de Llobregat, Barcelona, Spain., Vasen HFA; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands., Lubinski J; Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland., Scott RJ; Hunter Medical Research Institute, New Lambton Heights, Australia.; School of Biomedical Science and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia.; Division of Genetics, NSW Health Pathology, John Hunter Hospital, Newcastle, NSW, Australia., Talseth-Palmer BA; Research Unit, Ålesund Hospital, Møre and Romsdal Hospital Trust, Ålesund, Norway. bente.talseth-palmer@newcastle.edu.au.; Hunter Medical Research Institute, New Lambton Heights, Australia. bente.talseth-palmer@newcastle.edu.au.; School of Biomedical Science and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia. bente.talseth-palmer@newcastle.edu.au.
Publikováno v:
Scientific reports [Sci Rep] 2021 May 31; Vol. 11 (1), pp. 11401. Date of Electronic Publication: 2021 May 31.
Autor:
Xavier A; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia., Scott RJ; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.; NSW Health Pathology North, John Hunter Hospital, Newcastle, Australia., Talseth-Palmer BA; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.; Clinic for Research, Innovation, Education and Development, Møre and Romsdal Hospital Trust, Molde, Norway.
Publikováno v:
PLoS computational biology [PLoS Comput Biol] 2019 Oct 15; Vol. 15 (10), pp. e1007453. Date of Electronic Publication: 2019 Oct 15 (Print Publication: 2019).
Autor:
Xavier A; University of Newcastle Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia., Olsen MF; Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Medical Genetics, Saint Olavs Hospital University Hospital, Trondheim, Norway., Lavik LA; Department of Medical Genetics, Saint Olavs Hospital University Hospital, Trondheim, Norway., Johansen J; Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway., Singh AK; Department of Medical Genetics, Saint Olavs Hospital University Hospital, Trondheim, Norway., Sjursen W; Faculty of Medicine and Health Sciences, Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Medical Genetics, Saint Olavs Hospital University Hospital, Trondheim, Norway., Scott RJ; University of Newcastle Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Pathology North, Hunter New England Health, Newcastle, New South Wales, Australia., Talseth-Palmer BA; University of Newcastle Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.; Møre and Romsdal Hospital Trust, Clinic Research and Development, Molde, Norway.
Publikováno v:
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2019 Aug; Vol. 7 (8), pp. e850. Date of Electronic Publication: 2019 Jul 12.
Autor:
Andersen-Hollekim TE; Clinic of Medicine and Rehabilitation Møre and Romsdal Hospital Trust Ålesund Norway.; Faculty of Medicine and Health Sciences Norwegian University of Science and Technology Trondheim Norway., Kvangarsnes M; Department of Health Sciences, Faculty of Medicine and Health Sciences Norwegian University of Science and Technology Ålesund Norway.; Research Unit Møre and Romsdal Hospital Trust Ålesund Norway., Landstad BJ; Department of Health Sciences Mid Sweden University Östersund Sweden.; Levanger Hospital Nord-Trøndelag Hospital Trust Levanger Norway., Talseth-Palmer BA; Clinic of Medicine and Rehabilitation Møre and Romsdal Hospital Trust Ålesund Norway.; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences Norwegian University of Science and Technology Trondheim Norway.; School of Biomedical Science and Pharmacy, Faculty of Health and Medicine University of Newcastle and Hunter Medical Research Institute Newcastle Australia., Hole T; Clinic of Medicine and Rehabilitation Møre and Romsdal Hospital Trust Ålesund Norway.; Faculty of Medicine and Health Sciences Norwegian University of Science and Technology Trondheim Norway.
Publikováno v:
Nursing open [Nurs Open] 2019 Feb 14; Vol. 6 (2), pp. 574-582. Date of Electronic Publication: 2019 Feb 14 (Print Publication: 2019).
Autor:
Holmes M; 1School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW Australia.; 2Department of Surgery, John Hunter Hospital, Newcastle, Australia., Connor T; 1School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW Australia.; Pathology North, NSW Health Pathology, Newcastle, Australia., Oldmeadow C; 4Centre for Clinical Epidemiology and Biostatistics, University of Newcastle, Newcastle, NSW Australia., Pockney PG; 1School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW Australia.; 2Department of Surgery, John Hunter Hospital, Newcastle, Australia., Scott RJ; Pathology North, NSW Health Pathology, Newcastle, Australia.; 5School of Biomedical Science and Pharmacy, Faculty of Health and Medicine, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia., Talseth-Palmer BA; 5School of Biomedical Science and Pharmacy, Faculty of Health and Medicine, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.; 6Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Clinic for Medicine, Møre og Romsdal Hospital Trust, Molde, Norway.
Publikováno v:
Hereditary cancer in clinical practice [Hered Cancer Clin Pract] 2018 Jul 28; Vol. 16, pp. 14. Date of Electronic Publication: 2018 Jul 28 (Print Publication: 2018).
Autor:
Hansen MF; Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Pathology and Medical Genetics, St. Olavs University Hospital, Trondheim, Norway., Johansen J; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Sylvander AE; Department of Pathology and Medical Genetics, St. Olavs University Hospital, Trondheim, Norway., Bjørnevoll I; Department of Pathology and Medical Genetics, St. Olavs University Hospital, Trondheim, Norway., Talseth-Palmer BA; Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; School of Biomedical Science and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.; Clinic for Medicine, Møre and Romsdal Hospital Trust, Molde, Norway., Lavik LAS; Department of Pathology and Medical Genetics, St. Olavs University Hospital, Trondheim, Norway., Xavier A; School of Biomedical Science and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia., Engebretsen LF; Department of Pathology and Medical Genetics, St. Olavs University Hospital, Trondheim, Norway., Scott RJ; School of Biomedical Science and Pharmacy, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.; Division of Molecular Medicine Pathology North, NSW Pathology, Newcastle, Australia., Drabløs F; Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Sjursen W; Department of Laboratory Medicine, Children's and Women's Health, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Pathology and Medical Genetics, St. Olavs University Hospital, Trondheim, Norway.
Publikováno v:
Clinical genetics [Clin Genet] 2017 Oct; Vol. 92 (4), pp. 405-414. Date of Electronic Publication: 2017 Mar 22.
Autor:
Talseth-Palmer BA; Department of Laboratory Medicine, Children's and Women's Health, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, 7491 Norway.; Clinic for Medicine, Møre og Romsdal Hospital Trust, Molde, Norway.; School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW Australia.; Hunter Medical Research Institute, Newcastle, NSW Australia.; Clinic for Medicine, Library, Molde Hospital, Parkvegen 84, Molde, 6407 Norway.
Publikováno v:
Hereditary cancer in clinical practice [Hered Cancer Clin Pract] 2017 Mar 16; Vol. 15, pp. 5. Date of Electronic Publication: 2017 Mar 16 (Print Publication: 2017).